For the past 30 years, a diagnosis of acute myeloid leukemia (AML) has been a death sentence for many patients. Unlike most other forms of cancer, treatment advances have been few and far between, and an archaic chemo cocktail remains the decades-long standard of care. This has lead to the worst 5-year survival rate of any form of adult leukemia, and the hope for long-term survival little more than wishful thinking.
Now with Rydapt, the future has become brighter. As the first targeted agent approved in decades, patients will finally experience the benefit of sustained survival benefits. The Unicorn, embedded in everyday scenarios like the subway, represents how the myth of extended survival is finally a reality in AML.
This professional campaign titled 'Sports Fan Unicorn, Outdoor Market Unicorn, Subway Commut...' was published in United States in November, 2017. It was created for the brand: Novartis, by ad agency: Harrison and Star. This Print medium campaign is related to the Pharmaceutical industry and contains 3 media assets. It was submitted over 4 years ago.
Advertising Agency: Harrison And Star/Omnicom, New York, USA
Creative Directors: Mark Friedman, Mike Norkin, Dean Szostczuk, Josh Eastman
Art Directors: Dean Szostczuk, Matt Lee, Donna Tedesco, Matt Kemler
Copywriters: Josh Eastman, Garrett Allen, Brian McCoy
Photographer: Vincent Dixon
Digital Artists: Clive Biley, David Brungard, James Cullinane